🔎 Trials Near Me

홈 › 골수형성이상증후군 › 뉴욕

뉴욕의 골수형성이상증후군 임상 시험

골수형성이상증후군 관련 연구 38개가 뉴욕 내 여러 지역에서 참여자를 모집하고 있습니다.

뉴욕의 도시

공식 연구 텍스트(영어)

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

  • Roswell Park Cancer Institute, Buffalo
  • Stony Brook University Medical Center, Stony Brook
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06577441

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

  • Memorial Sloan Kettering Commack, Commack
  • Memorial Sloan Kettering Westchester, Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • 외 1개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06484062

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

  • Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중1상
12세 ~ 78세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT03802695

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • Roswell Park Cancer Institute, Buffalo
  • Memorial Sloan Kettering Commack, Commack
  • Northwell Health/Center for Advanced Medicine, Lake Success
  • 외 9개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05564390

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

  • Memorial Sloan Kettering Cancer Center, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Montefiore, New York
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT05320198

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  • Hematology Oncology Associates of Rockland, Nyack
  • Albert Einstein College - Montefiore, The Bronx
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07422480

Collection of Tissue Samples for Cancer Research

  • Roswell Park Cancer Institute, Buffalo
피험자 모집 중관찰 연구
2 Months · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT00900198

A Telehealth Advance Care Planning Intervention

  • University of Rochester, Rochester
피험자 모집 중
60세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT05875805

Cord Blood Transplant in Adults With Blood Cancers

  • Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중2상
21세 ~ 65세 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT05884333

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

  • MSKCC, New York
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06465953

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Albany Medical Center, Albany
  • Maimonides Medical Center, Brooklyn
  • NYU Langone Hospital - Long Island, Mineola
  • 외 7개
피험자 모집 중1/2상
22세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04726241

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  • Northwell Health, Lake Success
  • Clinical Research Alliance NY, Westbury
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT06499285

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

  • New York Cancer and Blood, Shirley
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT04419649

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

  • NYU Langone Health, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT06656494

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

  • Ichan School of Medicine at Mount Sinai, New York
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT05308264

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

  • Research Site, New York
피험자 모집 중1/2상
16세 이상 · 모든 성별 · 2026. 7. 20. 업데이트됨 · NCT07155226

Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens

  • Albany Medical Center, Albany
피험자 모집 중관찰 연구
30세 이하 · 모든 성별 · 2026. 7. 16. 업데이트됨 · NCT04968834

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • Weill Cornell Medicine - New York Presbyterian Hospital, New York
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT07216443

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

  • Wilmot Cancer Institute, University of Rochester, Rochester
피험자 모집 중초기 1상
18세 ~ 75세 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT03964506

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
피험자 모집 중2상
26세 이하 · 모든 성별 · 2026. 5. 14. 업데이트됨 · NCT07566377

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • New York University Langone Hospital - Long Island, Mineola
  • Perlmutter Cancer Center - 34th Street, New York
  • 외 2개
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 4. 30. 업데이트됨 · NCT04256317

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

  • Icahn School of Medicine at Mount Sinai, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 4. 13. 업데이트됨 · NCT06146257

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

  • The University of Rochester, Rochester
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 4. 13. 업데이트됨 · NCT05732103

Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

  • Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 3. 25. 업데이트됨 · NCT07107126

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  • Roswell Park Comprehensive Cancer Center, Buffalo
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 3. 24. 업데이트됨 · NCT04988555

FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia

  • Montefiore Medical Center, The Bronx
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 3. 3. 업데이트됨 · NCT07283094

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

  • Roswell Park Cancer Institute, Buffalo
  • New York University, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 1. 16. 업데이트됨 · NCT05143996

Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS

  • Montefiore Einstein Cancer Center and Children's Hospital at Montefiore (CHAM), The Bronx
피험자 모집 중1상
18세 ~ 75세 · 모든 성별 · 2026. 1. 8. 업데이트됨 · NCT05342584

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

  • Montefiore Medical Center, The Bronx
  • White Plains Hospital, White Plains
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 1. 5. 업데이트됨 · NCT05184842

Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

  • Montefiore Medical Center, The Bronx
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 12. 23. 업데이트됨 · NCT04245397

Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML

  • Montefiore Medical Center, The Bronx
피험자 모집 중1상건강한 지원자 환영
18세 이상 · 모든 성별 · 2025. 11. 10. 업데이트됨 · NCT05986240

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Buffalo
  • Massive Bio SYNERGY-AI site, Hempstead
  • Massive Bio SYNERGY-AI site, Manhasset
  • 외 2개
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

Umbilical Cord Blood Transplantation From Unrelated Donors

  • Wilmot Cancer Institute, Rochester
피험자 모집 중관찰 연구
2 Months – 75 Years · 모든 성별 · 2025. 10. 10. 업데이트됨 · NCT03016806

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

  • Roswell Park Cancer Institute, Buffalo
  • Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 9. 24. 업데이트됨 · NCT06501196

Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome

  • University of Rochester Medical Center, Rochester
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2025. 9. 17. 업데이트됨 · NCT01311258

Study of REM-422 in Patients With AML or Higher Risk MDS

  • Memorial Sloan Kettering, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 4. 23. 업데이트됨 · NCT06297941

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

  • Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 4. 15. 업데이트됨 · NCT06462365

A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

  • Memorial Sloan-Kettering Cancer Center, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2024. 3. 20. 업데이트됨 · NCT04243785

ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.